BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8018914)

  • 1. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation.
    Estellés A; Gilabert J; Keeton M; Eguchi Y; Aznar J; Grancha S; Espña F; Loskutoff DJ; Schleef RR
    Blood; 1994 Jul; 84(1):143-50. PubMed ID: 8018914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of PAI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardation.
    Grancha S; Estellés A; Gilabert J; Chirivella M; España F; Aznar J
    Thromb Haemost; 1996 Nov; 76(5):761-7. PubMed ID: 8950787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia.
    Estellés A; Gilabert J; Grancha S; Yamamoto K; Thinnes T; España F; Aznar J; Loskutoff DJ
    Thromb Haemost; 1998 Mar; 79(3):500-8. PubMed ID: 9580327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia.
    Jeyabalan A; McGonigal S; Gilmour C; Hubel CA; Rajakumar A
    Placenta; 2008 Jun; 29(6):555-63. PubMed ID: 18462791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uteroplacental hemostasis in intrauterine fetal growth retardation.
    Sheppard BL; Bonnar J
    Semin Thromb Hemost; 1999; 25(5):443-6. PubMed ID: 10625199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mast cells, histamine and development of the placental vascular network in pregnancies complicated by preeclampsia and intrauterine growth retardation].
    Szewczyk G; Szewczyk A; Pyzlak M; Klimkiewicz J; Smiertka W; Szukiewicz D
    Ginekol Pol; 2005 Sep; 76(9):727-34. PubMed ID: 16417085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of 52-kDa FK506-binding protein (FKBP52) in human placenta complicated by preeclampsia and intrauterine growth restriction.
    Acar N; Ustunel I
    Anal Quant Cytopathol Histpathol; 2015 Apr; 37(2):87-95. PubMed ID: 26065228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas and FasL expression in placentas complicated with intrauterine growth retardation with and without preeclampsia.
    Rešić Karara J; Zekić Tomas S; Marušić J; Roje D; Kuzmić Prusac I
    J Matern Fetal Neonatal Med; 2016; 29(7):1154-9. PubMed ID: 25909501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
    Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
    Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered mRNA expression pattern of placental epidermal growth factor receptor (EGFR) in pregnancies complicated by preeclampsia and/or intrauterine growth retardation.
    Faxén M; Nasiell J; Blanck A; Nisell H; Lunell NO
    Am J Perinatol; 1998 Jan; 15(1):9-13. PubMed ID: 9475680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease.
    Estellés A; Grancha S; Gilabert J; Thinnes T; Chirivella M; España F; Aznar J; Loskutoff DJ
    Am J Pathol; 1996 Oct; 149(4):1229-39. PubMed ID: 8863672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental ABCA1 and ABCG1 expression in gestational disease: Pre-eclampsia affects ABCA1 levels in syncytiotrophoblasts.
    Baumann M; Körner M; Huang X; Wenger F; Surbek D; Albrecht C
    Placenta; 2013 Nov; 34(11):1079-86. PubMed ID: 23880356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential release of plasminogen activator inhibitors (PAIs) during dual perfusion of human placenta: implications in preeclampsia.
    Guller S; Ma Y; Malek A; Di Santo S; Schneider H
    Placenta; 2007 Apr; 28(4):278-85. PubMed ID: 16820203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction.
    Lorenzi T; Marzioni D; Giannubilo S; Quaranta A; Crescimanno C; De Luca A; Baldi A; Todros T; Tranquilli AL; Castellucci M
    Placenta; 2009 Jan; 30(1):35-40. PubMed ID: 19056122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterine fetal growth retardation.
    Gilabert J; Estellés A; Ayuso MJ; España F; Chirivella M; Grancha S; Micó JM; Aznar J
    Gynecol Obstet Invest; 1994; 38(3):157-62. PubMed ID: 8001867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of N-myc downstream-regulated gene 1 (NDRG1) in placentas from pregnancies complicated by intrauterine growth restriction or preeclampsia.
    Choi SJ; Oh SY; Kim JH; Sadovsky Y; Roh CR
    Am J Obstet Gynecol; 2007 Jan; 196(1):45.e1-7. PubMed ID: 17240229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome.
    Fruscalzo A; Schmitz R; Klockenbusch W; Köhler G; Londero AP; Siwetz M; Huppertz B
    Histochem Cell Biol; 2012 Dec; 138(6):925-32. PubMed ID: 22847813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-eclampsia onset and SPARC: A possible involvement in placenta development.
    Tossetta G; Fantone S; Giannubilo SR; Marinelli Busilacchi E; Ciavattini A; Castellucci M; Di Simone N; Mattioli-Belmonte M; Marzioni D
    J Cell Physiol; 2019 May; 234(5):6091-6098. PubMed ID: 30426491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of placental nutrient transporters associated with intrauterine growth restriction and pre-eclampsia.
    Huang X; Anderle P; Hostettler L; Baumann MU; Surbek DV; Ontsouka EC; Albrecht C
    BMC Genomics; 2018 Mar; 19(1):173. PubMed ID: 29499643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia.
    Holdsworth-Carson SJ; Lim R; Mitton A; Whitehead C; Rice GE; Permezel M; Lappas M
    Placenta; 2010 Mar; 31(3):222-9. PubMed ID: 20045185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.